Effects of bucindolol on cardiovascular mortality and morbidity are determined by the beta-1 389 Arg/Gly receptor polymorphism
Publication
, Conference
White, M; Carson, P; Anand, IS; Gottlieb, SS; Lindenfeld, J; O'Connor, C; Miller, A; Plehn, J; Silver, MA; Fiuzat, M; Robertson, AD; Bristow, MR
Published in: CIRCULATION
October 16, 2007
Duke Scholars
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
October 16, 2007
Volume
116
Issue
16
Start / End Page
176 / 176
Location
Orlando, FL
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
80th Annual Scientific Session of the American-Heart-Association
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
White, M., Carson, P., Anand, I. S., Gottlieb, S. S., Lindenfeld, J., O’Connor, C., … Bristow, M. R. (2007). Effects of bucindolol on cardiovascular mortality and morbidity are determined by the beta-1 389 Arg/Gly receptor polymorphism. In CIRCULATION (Vol. 116, pp. 176–176). Orlando, FL: LIPPINCOTT WILLIAMS & WILKINS.
White, Michel, Peter Carson, Inder S. Anand, Stephen S. Gottlieb, JoAnn Lindenfeld, Christopher O’Connor, Alan Miller, et al. “Effects of bucindolol on cardiovascular mortality and morbidity are determined by the beta-1 389 Arg/Gly receptor polymorphism.” In CIRCULATION, 116:176–176. LIPPINCOTT WILLIAMS & WILKINS, 2007.
White M, Carson P, Anand IS, Gottlieb SS, Lindenfeld J, O’Connor C, et al. Effects of bucindolol on cardiovascular mortality and morbidity are determined by the beta-1 389 Arg/Gly receptor polymorphism. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2007. p. 176–176.
White, Michel, et al. “Effects of bucindolol on cardiovascular mortality and morbidity are determined by the beta-1 389 Arg/Gly receptor polymorphism.” CIRCULATION, vol. 116, no. 16, LIPPINCOTT WILLIAMS & WILKINS, 2007, pp. 176–176.
White M, Carson P, Anand IS, Gottlieb SS, Lindenfeld J, O’Connor C, Miller A, Plehn J, Silver MA, Fiuzat M, Robertson AD, Bristow MR. Effects of bucindolol on cardiovascular mortality and morbidity are determined by the beta-1 389 Arg/Gly receptor polymorphism. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2007. p. 176–176.
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
October 16, 2007
Volume
116
Issue
16
Start / End Page
176 / 176
Location
Orlando, FL
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
80th Annual Scientific Session of the American-Heart-Association
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology